<?xml version="1.0" encoding="iso-8859-1" ?>
<rss version="2.0" xmlns:s="http://resources.bnet.com/">
<channel>
	<title><![CDATA[michael becker Resources | BNET]]></title>
	<link><![CDATA[http://resources.bnet.com/topic/michael+becker.html]]></link>
	<description><![CDATA[White papers, case studies, business articles, and blog posts relating to michael becker]]></description>
	<s:counts start="0" returned="2" found="2" />
	<language>en-us</language>
	<item>
		<title><![CDATA[Can Spectrum Pharmaceuticals Benefit from FDA Action on Zevalin?]]></title>
		<link><![CDATA[http://dw.com.com/redir?destUrl=http%3A%2F%2Fseekingalpha.com%2Farticle%2F146382-can-spectrum-pharmaceuticals-benefit-from-fda-action-on-zevalin%3Fsource%3Dbnet&siteid=23&tag=seekingalpha]]></link>
		<description><![CDATA[Michael Becker submits: According to the American Cancer Society [ACS], non-Hodgkin lymphoma [also known as non-Hodgkin&#8217;s lymphoma, NHL, or sometimes just lymphoma] is a cancer that starts in cells of the lymph system, which is part of the body&#8217;s immune system.  NHL is the fifth most common cancer in...]]></description>
		<s:doctype><![CDATA[External links]]></s:doctype>
		<pubDate>Wed, 01 Jul 2009 02:16:33 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/biotech.html"><![CDATA[Biotech]]></category>
		<category domain="http://resources.bnet.com/topic/healthcare.html"><![CDATA[Healthcare]]></category>
		<category domain="http://resources.bnet.com/topic/michael+becker.html"><![CDATA[Michael Becker]]></category>
		<category domain="http://resources.bnet.com/topic/glaxosmithkline+plc..html"><![CDATA[GlaxoSmithKline Plc.]]></category>
		<category domain="http://resources.bnet.com/topic/spectrum+pharmaceuticals+inc..html"><![CDATA[Spectrum Pharmaceuticals Inc.]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">GSK</category>
		<category domain="http://rss.financialcontent.com/stocksymbol">SPPI</category>
		<category domain="tickers">GSK,SPPI</category>
	</item>
	<item>
		<title><![CDATA[Much Ado About Medarex]]></title>
		<link><![CDATA[http://dw.com.com/redir?destUrl=http%3A%2F%2Fseekingalpha.com%2Farticle%2F145305-much-ado-about-medarex%3Fsource%3Dbnet&siteid=23&tag=seekingalpha]]></link>
		<description><![CDATA[Michael Becker submits: According to their website, Discovery&#8217;s Edge is the Mayo Clinic&#8217;s online research magazine that is designed to communicate the story of scientists and researchers who are bringing treatments and improved care to patients and also reports on &#8220;works&#8211;in&#8211;progress.&#8221;  Through this publication, Mayo investigators studying immunotherapy for...]]></description>
		<s:doctype><![CDATA[External links]]></s:doctype>
		<pubDate>Thu, 25 Jun 2009 04:24:55 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/biotech.html"><![CDATA[Biotech]]></category>
		<category domain="http://resources.bnet.com/topic/michael+becker.html"><![CDATA[Michael Becker]]></category>
		<category domain="http://resources.bnet.com/topic/medarex+inc..html"><![CDATA[Medarex Inc.]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">MEDX</category>
		<category domain="tickers">MEDX</category>
	</item>
</channel>
</rss>
